
Centene Corp (NYSE:CNC) stock is rallying Thursday after the insurer confirmed its fiscal 2025 outlook of roughly $1.75 adjusted EPS—beating Wall Street's $1.69 consensus—despite having pulled prior guidance in July over preliminary actuarial data concerns.
The company reported second-quarter sales surged 22% year-over-year to $48.74 billion, comfortably exceeding the consensus estimate of $44.48 billion.